Explore StockAnalysis 👉👉 https://stockanalysis.com/pro/?ref=itp
Super light-weight stock analysis & deep dive tool for your smart decisions.

🎟️ Use code ""ITP"" for 10% off.

StockAnalysis is a lightweight stock research platform that works on desktop, iOS, and Android. The free version is useful for checking stock prices, financials, charts, forecasts, and news.

For deeper research, StockAnalysis Pro includes no ads, saved screeners, watchlists, portfolios, long-term financial history, dividend history, analyst filters, ETF data, and exports to Excel, CSV, and Google Sheets.

Pro Annual: about $5.93/month after discount when billed annually
Unlimited Annual: about $14.93/month after discount when billed annually

StockAnalysis is a research tool, not financial advice. It does not tell you what to buy or sell or guarantee investment results.

______________________________________

Start your 14-day StockOracle trial here 👉👉 https://www.getstockoracle.com/GZHPZ/3QQG7/?source_id=itp&rotate_uid=1

StockOracle is an AI-aided stock research platform that brings company fundamentals, valuation estimates, competitive-moat analysis, bull and bear insights, stock comparisons, watchlists, and portfolio tools into one place.

Its OracleIQ Stock Appraiser helps identify financial strengths and warning signs, while OracleValue provides intrinsic-value estimates using several valuation models. These tools can help you research both the opportunities and risks surrounding a stock.

StockOracle is a research tool, not financial advice. Its AI insights and valuation estimates may be incomplete or incorrect, and market data may be delayed. Always verify important information and conduct your own research.

______________________________________

Check out VIP Algos for Buy & Sell signals 👉👉 https://hop.clickbank.net/?affiliate=itp129&vendor=fxlife

Starting as low as $9 per month. VIP Algos helps traders use TradingView indicators, clean alerts, setup support, and education to organize chart analysis.

Important: Trading is risky. VIP Algos does not guarantee profits or results. Use it as an educational chart tool only.

______________________________________

Can partnership cash and clinical validation offset financing pressure? This ITP episode examines Recursion, Tempus AI, Schrödinger, Alector and PDS Biotechnology using the supplied market data and company-filing analysis as of the October 5, 2026 session.

Episode date: October 6, 2026

CHAPTERS
0:00 Deals, data and cash risk
0:36 RXRX — Recursion partner funding
1:53 TEM — Tempus profitability test
3:06 SDGR — Schrödinger milestone economics
4:18 ALEC — Alector license and cash pressure
5:33 PDSB — Clinical data and contingent financing
7:02 Five company checkpoints

Music: Tuesday Vibes by Snoozybeats

#BiotechStocks #AIHealthcare #StockAnalysis #InvestingTalkPodcast

______________________________________

New episodes daily. Subscribe to stay ahead of the market:
https://youtube.com/channel/UCsDCdVOP_zMugTEwIAfl48A/?sub_confirmation=1

Support the show:
https://buymeacoffee.com/investingtalkpodcast

Disclaimer: This content is for education and information only. We are not financial advisors. Always do your own research before investing.

#StockMarket #Investing #Finance #Stocks #Trading #SP500 #Nasdaq #ETF #DividendInvesting

#stockmarket #investing #sp500 #nasdaq #finance #stockmarket2026 #beststocks2026 #aistocks #passiveincome #dividends #fedratecut #inflation

Explore StockAnalysis 👉👉 https://stockanalysis.com/pro/?ref=itp
Super light-weight stock analysis & deep dive tool for your smart decisions.

🎟️ Use code ""ITP"" for 10% off.

StockAnalysis is a lightweight stock research platform that works on desktop, iOS, and Android. The free version is useful for checking stock prices, financials, charts, forecasts, and news.

For deeper research, StockAnalysis Pro includes no ads, saved screeners, watchlists, portfolios, long-term financial history, dividend history, analyst filters, ETF data, and exports to Excel, CSV, and Google Sheets.

Pro Annual: about $5.93/month after discount when billed annually
Unlimited Annual: about $14.93/month after discount when billed annually

StockAnalysis is a research tool, not financial advice. It does not tell you what to buy or sell or guarantee investment results.

______________________________________

Start your 14-day StockOracle trial here 👉👉 https://www.getstockoracle.com/GZHPZ/3QQG7/?source_id=itp&rotate_uid=1

StockOracle is an AI-aided stock research platform that brings company fundamentals, valuation estimates, competitive-moat analysis, bull and bear insights, stock comparisons, watchlists, and portfolio tools into one place.

Its OracleIQ Stock Appraiser helps identify financial strengths and warning signs, while OracleValue provides intrinsic-value estimates using several valuation models. These tools can help you research both the opportunities and risks surrounding a stock.

StockOracle is a research tool, not financial advice. Its AI insights and valuation estimates may be incomplete or incorrect, and market data may be delayed. Always verify important information and conduct your own research.

______________________________________

Check out VIP Algos for Buy & Sell signals 👉👉 https://hop.clickbank.net/?affiliate=itp129&vendor=fxlife

Starting as low as $9 per month. VIP Algos helps traders use TradingView indicators, clean alerts, setup support, and education to organize chart analysis.

Important: Trading is risky. VIP Algos does not guarantee profits or results. Use it as an educational chart tool only.

______________________________________

Tesla, NVIDIA, Marvell, Micron & Intel: What Comes After the Good News?

Five stocks in chips, memory and electric vehicles face a common question: can the next checkpoint extend the recent good news? This October 4, 2026 Investing Talk Podcast episode discusses company-specific developments tied to the October 2 trading session.

We examine Tesla’s delivery beat and autonomy expectations, NVIDIA’s Vera Rubin ramp and reported customer financing, Marvell’s Investor Day and two data center spending channels, Micron’s contracted supply and peak-cycle risk, and Intel’s revenue step against capital intensity and GAAP losses.

CHAPTERS
00:00 Introduction & disclosure
00:38 TSLA: Deliveries, autonomy & profitability
02:04 NVDA: Vera Rubin & demand financing
03:31 MRVL: Investor Day & growth targets
04:59 MU: Contracted supply or cycle peak?
06:27 INTC: Foundry optionality & capital intensity
07:52 Five stocks: the next checkpoints

WHAT TO WATCH
• Tesla: the earnings call expected around October 21; does the delivery beat become margin and cash? The possible Tesla–SpaceX combination remains unconfirmed commentary.
• NVIDIA: November 25 earnings; Vera Rubin’s anticipated revenue contribution is a forecast. The reported Amazon financing arrangement adds demand-quality and counterparty questions.
• Marvell: confirmed October 6 Investor Day; listen for customer concentration, margins and the growth framework. The reported $12B fiscal 2027 target has limited provenance and is not confirmed guidance.
• Micron: the next earnings date is unconfirmed. Minimum supply commitments and upfront deposits differ from current booked revenue; profit durability is the test.
• Intel: October 22 earnings; watch whether sequential revenue growth holds while GAAP losses narrow. Design-kit timing and future customers remain expectations, with no signed external-customer contract supplied.

#Tesla #NVIDIA #Marvell #Micron #Intel #SemiconductorStocks #InvestingTalkPodcast

______________________________________

New episodes daily. Subscribe to stay ahead of the market:
https://youtube.com/channel/UCsDCdVOP_zMugTEwIAfl48A/?sub_confirmation=1

Support the show:
https://buymeacoffee.com/investingtalkpodcast

Disclaimer: This content is for education and information only. We are not financial advisors. Always do your own research before investing.

#StockMarket #Investing #Finance #Stocks #Trading #SP500 #Nasdaq #ETF #DividendInvesting #VKTX #SNDK #SHOP #MU #INTC

#stockmarket #investing #sp500 #nasdaq #finance #stockmarket2026 #beststocks2026 #aistocks #passiveincome #dividends #fedratecut #inflation

Explore StockAnalysis 👉👉 https://stockanalysis.com/pro/?ref=itp
Super light-weight stock analysis & deep dive tool for your smart decisions.

🎟️ Use code ""ITP"" for 10% off.

StockAnalysis is a lightweight stock research platform that works on desktop, iOS, and Android. The free version is useful for checking stock prices, financials, charts, forecasts, and news.

For deeper research, StockAnalysis Pro includes no ads, saved screeners, watchlists, portfolios, long-term financial history, dividend history, analyst filters, ETF data, and exports to Excel, CSV, and Google Sheets.

Pro Annual: about $5.93/month after discount when billed annually
Unlimited Annual: about $14.93/month after discount when billed annually

StockAnalysis is a research tool, not financial advice. It does not tell you what to buy or sell or guarantee investment results.

______________________________________

Start your 14-day StockOracle trial here 👉👉 https://www.getstockoracle.com/GZHPZ/3QQG7/?source_id=itp&rotate_uid=1

StockOracle is an AI-aided stock research platform that brings company fundamentals, valuation estimates, competitive-moat analysis, bull and bear insights, stock comparisons, watchlists, and portfolio tools into one place.

Its OracleIQ Stock Appraiser helps identify financial strengths and warning signs, while OracleValue provides intrinsic-value estimates using several valuation models. These tools can help you research both the opportunities and risks surrounding a stock.

StockOracle is a research tool, not financial advice. Its AI insights and valuation estimates may be incomplete or incorrect, and market data may be delayed. Always verify important information and conduct your own research.

______________________________________

Check out VIP Algos for Buy & Sell signals 👉👉 https://hop.clickbank.net/?affiliate=itp129&vendor=fxlife

Starting as low as $9 per month. VIP Algos helps traders use TradingView indicators, clean alerts, setup support, and education to organize chart analysis.

Important: Trading is risky. VIP Algos does not guarantee profits or results. Use it as an educational chart tool only.

______________________________________

Lumen, Ciena, GFS, Lightwave & LightPath: AI Networks Meet the Revenue Test

AI networks, semiconductor manufacturing, photonics and defense optics offer five very different investment setups. This October 4, 2026 Investing Talk Podcast episode uses the October 2 trading session for all share-price references.

We examine Lumen’s AI connectivity contracts, Ciena’s record growth and fiscal 2029 targets, GlobalFoundries’ government funding and Singapore manufacturing agreement, Lightwave Logic’s pre-commercial revenue base, and LightPath’s defense backlog against losses and cash burn.

CHAPTERS
00:00 Introduction & disclosure
00:36 LUMN: AI contracts versus legacy decline
01:58 CIEN: Record growth and 2029 targets
03:12 GFS: Funding, manufacturing and the growth test
04:34 LWLG: Commercialization, runway and dilution
05:53 LPTH: Defense backlog versus cash burn
07:21 Five stocks: the next checkpoints

WHAT TO WATCH
• Lumen: Q3 earnings on November 4. Can reported private-connectivity contracts become recognized revenue? Contract value differs from sales, and the supplied current debt picture is incomplete.
• Ciena: fiscal Q4 earnings expected December 10. Its fiscal 2029 revenue and margin goals are management targets, not forecasts. The latest cash build came mainly from borrowing.
• GlobalFoundries: Q3 call on November 4. The finalized $375M R&D award differs from the $300M letter of intent; early 2027 is a manufacturing target. Annual revenue was roughly flat despite a profit swing whose cause is unexplained in the source.
• Lightwave Logic: no confirmed next earnings date. Watch filings for commercialization and revenue progress. The first-half revenue base was about $62K; the spoken recap’s “no revenue yet” is shorthand inconsistent with that figure. The 2027 expectation is third-party commentary, and runway is current-burn arithmetic.
• LightPath: no confirmed next earnings date. Does defense backlog convert to revenue while losses narrow? Expected conversion, follow-on orders, recognized sales and equity financing are distinct.

#Lumen #Ciena #GlobalFoundries #LightwaveLogic #LightPath #AIInfrastructure #InvestingTalkPodcast

______________________________________

New episodes daily. Subscribe to stay ahead of the market:
https://youtube.com/channel/UCsDCdVOP_zMugTEwIAfl48A/?sub_confirmation=1

Support the show:
https://buymeacoffee.com/investingtalkpodcast

Disclaimer: This content is for education and information only. We are not financial advisors. Always do your own research before investing.

#StockMarket #Investing #Finance #Stocks #Trading #SP500 #Nasdaq #ETF #DividendInvesting #VKTX #SNDK #SHOP #MU #INTC

#stockmarket #investing #sp500 #nasdaq #finance #stockmarket2026 #beststocks2026 #aistocks #passiveincome #dividends #fedratecut #inflation

Explore StockAnalysis 👉👉 https://stockanalysis.com/pro/?ref=itp
Super light-weight stock analysis & deep dive tool for your smart decisions.

🎟️ Use code ""ITP"" for 10% off.

StockAnalysis is a lightweight stock research platform that works on desktop, iOS, and Android. The free version is useful for checking stock prices, financials, charts, forecasts, and news.

For deeper research, StockAnalysis Pro includes no ads, saved screeners, watchlists, portfolios, long-term financial history, dividend history, analyst filters, ETF data, and exports to Excel, CSV, and Google Sheets.

Pro Annual: about $5.93/month after discount when billed annually
Unlimited Annual: about $14.93/month after discount when billed annually

StockAnalysis is a research tool, not financial advice. It does not tell you what to buy or sell or guarantee investment results.

______________________________________

Start your 14-day StockOracle trial here 👉👉 https://www.getstockoracle.com/GZHPZ/3QQG7/?source_id=itp&rotate_uid=1

StockOracle is an AI-aided stock research platform that brings company fundamentals, valuation estimates, competitive-moat analysis, bull and bear insights, stock comparisons, watchlists, and portfolio tools into one place.

Its OracleIQ Stock Appraiser helps identify financial strengths and warning signs, while OracleValue provides intrinsic-value estimates using several valuation models. These tools can help you research both the opportunities and risks surrounding a stock.

StockOracle is a research tool, not financial advice. Its AI insights and valuation estimates may be incomplete or incorrect, and market data may be delayed. Always verify important information and conduct your own research.

______________________________________

Check out VIP Algos for Buy & Sell signals 👉👉 https://hop.clickbank.net/?affiliate=itp129&vendor=fxlife

Starting as low as $9 per month. VIP Algos helps traders use TradingView indicators, clean alerts, setup support, and education to organize chart analysis.

Important: Trading is risky. VIP Algos does not guarantee profits or results. Use it as an educational chart tool only.

______________________________________

Five crypto-linked stocks, five different execution tests. This October 5, 2026 Investing Talk Podcast episode uses the October 2 market session to examine Coinbase (COIN), Circle (CRCL), Strategy (MSTR), Strive (ASST) and Bitmine (BMNR).

Can licensed clearing, bank settlement and digital-asset accumulation translate into durable financial results? We compare the reported developments with revenue, losses, funding obligations and the next disclosures to watch.

CHAPTERS
00:00 Crypto infrastructure versus reported losses
00:42 COIN — Coinbase clearing and payments
02:16 CRCL — Circle and bank settlement
04:00 MSTR — Strategy's bitcoin treasury
05:35 ASST — Strive's preferred funding
07:06 BMNR — Bitmine's Ethereum treasury
08:36 The next disclosure test

IN THIS EPISODE
• COIN: CFTC clearing approval and Citi payment collaboration; infrastructure revenue contribution remains unproven.
• CRCL: Arc, USDC and Volante bank integration; reported Tazapay closing remains subject to approval. H1 2026 income and FY 2025 loss cover different periods.
• MSTR: Continued bitcoin purchases, digital-asset accounting losses and an unclear issuance effect on exposure per share.
• ASST: SATA preferred funding at a 13% annual rate, October dividends and an undisclosed cash-versus-accounting loss split.
• BMNR: Reported ETH accumulation near its supply target, increasing treasury assets and a large loss with an undisclosed cause.

#CryptoStocks #COIN #CRCL #MSTR #ASST #BMNR

______________________________________

New episodes daily. Subscribe to stay ahead of the market:
https://youtube.com/channel/UCsDCdVOP_zMugTEwIAfl48A/?sub_confirmation=1

Support the show:
https://buymeacoffee.com/investingtalkpodcast

Disclaimer: This content is for education and information only. We are not financial advisors. Always do your own research before investing.

#StockMarket #Investing #Finance #Stocks #Trading #SP500 #Nasdaq #ETF #DividendInvesting

#stockmarket #investing #sp500 #nasdaq #finance #stockmarket2026 #beststocks2026 #aistocks #passiveincome #dividends #fedratecut #inflation

Explore StockAnalysis 👉👉 https://stockanalysis.com/pro/?ref=itp
Super light-weight stock analysis & deep dive tool for your smart decisions.

🎟️ Use code ""ITP"" for 10% off.

StockAnalysis is a lightweight stock research platform that works on desktop, iOS, and Android. The free version is useful for checking stock prices, financials, charts, forecasts, and news.

For deeper research, StockAnalysis Pro includes no ads, saved screeners, watchlists, portfolios, long-term financial history, dividend history, analyst filters, ETF data, and exports to Excel, CSV, and Google Sheets.

Pro Annual: about $5.93/month after discount when billed annually
Unlimited Annual: about $14.93/month after discount when billed annually

StockAnalysis is a research tool, not financial advice. It does not tell you what to buy or sell or guarantee investment results.

______________________________________

Start your 14-day StockOracle trial here 👉👉 https://www.getstockoracle.com/GZHPZ/3QQG7/?source_id=itp&rotate_uid=1

StockOracle is an AI-aided stock research platform that brings company fundamentals, valuation estimates, competitive-moat analysis, bull and bear insights, stock comparisons, watchlists, and portfolio tools into one place.

Its OracleIQ Stock Appraiser helps identify financial strengths and warning signs, while OracleValue provides intrinsic-value estimates using several valuation models. These tools can help you research both the opportunities and risks surrounding a stock.

StockOracle is a research tool, not financial advice. Its AI insights and valuation estimates may be incomplete or incorrect, and market data may be delayed. Always verify important information and conduct your own research.

______________________________________

Check out VIP Algos for Buy & Sell signals 👉👉 https://hop.clickbank.net/?affiliate=itp129&vendor=fxlife

Starting as low as $9 per month. VIP Algos helps traders use TradingView indicators, clean alerts, setup support, and education to organize chart analysis.

Important: Trading is risky. VIP Algos does not guarantee profits or results. Use it as an educational chart tool only.

______________________________________

Moderna’s Valuation Test, Bloom’s Power Bet & Intel’s Turnaround | 5 Stocks

Investing Talk Podcast — October 1, 2026 episode, covering the September 30 market session.

Pipeline milestones, AI power demand, chip manufacturing, networking margins and a new product cycle: five stocks face very different execution tests.

• Moderna (MRNA): a Citigroup downgrade challenges the valuation after a huge rally. Flu-vaccine approval and cancer trial results meet losses and cash burn.
• Bloom Energy (BE): record quarterly results and Oracle’s reaffirmed Project Jupiter commitment connect the business to AI power demand, with concentration and execution risks.
• Intel (INTC): reported manufacturing progress and positive half-year free-cash-flow proxy meet a large GAAP loss, debt and the external-customer test.
• Hewlett Packard Enterprise (HPE): a Vultr order and raised networking targets support the AI case, while acquisition effects and execution matter.
• Apple (AAPL): reported product dates and strong cash generation meet a rich valuation and competitive pressure.

CHAPTERS
00:00 Introduction & disclosures
00:42 Moderna: pipeline milestones versus valuation
02:30 Bloom Energy: Project Jupiter and concentration
04:03 Intel: manufacturing progress and cash flow
05:43 HPE: AI networking and margin targets
07:18 Apple: product cycle, margins and cash
08:47 Recap: five execution tests

CHECKPOINTS FROM THE EPISODE
Moderna: cancer data webcast reported for October 24 and Q3 earnings reported for October 29; neither date independently confirmed in the supplied material.
Bloom Energy: Q3 earnings confirmed for October 29 after the close.
Intel: earnings scheduled for October 22. The second-half 2026 external-customer decision window comes from a prediction article, not a company commitment.
HPE: fiscal Q4 earnings date remains unconfirmed.
Apple: smart-home hub release October 13; iPhone Duo pre-orders reported for October 16 and retail delivery October 23. Earnings reported for October 29 after the close; fiscal period covered is unconfirmed.

#MRNA #BE #INTC #HPE #AAPL #InvestingTalkPodcast

______________________________________

New episodes daily. Subscribe to stay ahead of the market:
https://youtube.com/channel/UCsDCdVOP_zMugTEwIAfl48A/?sub_confirmation=1

Support the show:
https://buymeacoffee.com/investingtalkpodcast

Disclaimer: This content is for education and information only. We are not financial advisors. Always do your own research before investing.

#StockMarket #Investing #Finance #Stocks #Trading #SP500 #Nasdaq #ETF #DividendInvesting #VKTX #SNDK #SHOP #MU #INTC

#stockmarket #investing #sp500 #nasdaq #finance #stockmarket2026 #beststocks2026 #aistocks #passiveincome #dividends #fedratecut #inflation